KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Travere Therapeutics (TVTX) over the last 12 years, with Q3 2025 value amounting to 1.04%.

  • Travere Therapeutics' Return on Invested Capital rose 123800.0% to 1.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.04%, marking a year-over-year increase of 123800.0%. This contributed to the annual value of 1.97% for FY2024, which is 11300.0% up from last year.
  • According to the latest figures from Q3 2025, Travere Therapeutics' Return on Invested Capital is 1.04%, which was up 123800.0% from 1.69% recorded in Q2 2025.
  • Travere Therapeutics' 5-year Return on Invested Capital high stood at 0.64% for Q2 2021, and its period low was 13.42% during Q3 2024.
  • Moreover, its 5-year median value for Return on Invested Capital was 1.89% (2023), whereas its average is 2.84%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first crashed by -115300bps in 2024, then soared by 123800bps in 2025.
  • Over the past 5 years, Travere Therapeutics' Return on Invested Capital (Quarter) stood at 0.65% in 2021, then tumbled by -526bps to 4.06% in 2022, then soared by 60bps to 1.62% in 2023, then crashed by -142bps to 3.91% in 2024, then surged by 73bps to 1.04% in 2025.
  • Its Return on Invested Capital stands at 1.04% for Q3 2025, versus 1.69% for Q2 2025 and 1.98% for Q1 2025.